Study of ARO-APOC3 in Adults With Dyslipidemia

NCT05413135 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

418

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: ARO-APOC3

Sponsor

Arrowhead Pharmaceuticals